Current News

MBS expands Osteopontin Products
Osteopontin (OPN) is a well-characterized secreted protein found in the circulation and is emerging as a potential biomarker for many cancers. Maine Biotechnology Services, Inc.(MBS), developed seven anti-human OPN monoclonal Antibodies, recognizing the C terminal, N Terminal and DSVVYG peptide.

MBS is Offering New Monoclonal Antibodies to PEG
Maine Biotechnology Services has developed two antibodies that recognize the linear backbone of Polyethylene glycol (PEG). There are broad applications for these antibodies in both production and R&D settings. Our PEG antibodies can be a vital tool for propelling therapeutics to market by serving as a positive control anti-drug antibody, measuring clearance of a drug, or simply in a western blot as a QA release confirming PEGylation.

MBS Adds two Antibodies to Human Myeloperoxidase
MBS R&D is introducing two new anti-human Myeloperoxidase monoclonal antibodies. Contact us to order the two antibodies recognizing Myeloperoxidase (MPO), a well documented biomarker for immune deficiency and myocardial infarction. The antibodies were developed in-house and validated as a matched pair in a sandwich ELISA format